This pack has been prepared to aid discussion and provide further supplementary information only and has not been subject to an external review or audit -- 1 of 15 -- CUSTOMERS PER ENTITY Life Policyholders June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 449 211 449 300 447 690 449 130 449 020 449 378 448 313 445 813 446 713 452 561 446 475 Invest Invest - DRO 137 503 137 718 137 189 135 819 134 721 133 741 132 817 131 244 129 606 127 831 124 135 Invest - Other 229 871 225 414 221 273 216 479 212 161 206 778 201 210 195 231 192 615 189 210 185 025 Group (lives) 711 051 707 756 711 161 680 754 584 081 562 769 576 450 562 440 578 035 551 219 544 443 Group schemes 2 616 2 647 2 663 2 666 2 793 2 844 2 827 2 825 2 797 2 740 2 771 Life NB APE 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to R million June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 2 778 1 444 2 663 1 355 2 362 1 204 2 072 1 068 2 126 1 165 2 215 Group 164 75 175 130 181 64 193 94 160 75 97 Invest - Recurring 1 673 851 1 551 796 1 428 737 1 167 573 1 164 686 1 221 Invest - Single APE1 1 627 778 1 500 708 1 493 782 1 570 744 1 508 671 1 382 Total Life APE 6 242 3 148 5 889 2 990 5 464 2 786 5 001 2 478 4 958 2 597 4 915 1 APE shown at 10% of Single premium Health Members June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 DHMS - Keycare 207 934 226 848 225 517 232 988 232 055 234 421 235 841 230 960 232 714 243 046 240 140 DHMS - Non-Keycare 1 152 395 1 147 016 1 149 861 1 142 556 1 135 853 1 118 591 1 111 545 1 099 553 1 111 079 1 108 674 1 110 401 In-House Schemes 354 944 321 333 319 813 321 838 318 246 316 973 321 613 321 767 319 974 317 408 316 410 Total 1 715 273 1 695 197 1 695 191 1 697 382 1 686 154 1 669 985 1 668 999 1 652 280 1 663 767 1 669 128 1 666 951 Health Lives June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 DHMS - Keycare 350 038 385 906 384 759 398 397 397 595 401 307 404 984 400 108 403 392 420 869 415 436 DHMS - Non-Keycare 2 394 452 2 402 336 2 413 851 2 412 595 2 406 528 2 383 486 2 375 082 2 358 232 2 381 735 2 387 237 2 394 336 In-House Schemes 798 933 710 485 707 406 710 427 704 472 699 342 707 293 704 749 698 534 689 688 686 114 Total 3 543 423 3 498 727 3 506 016 3 521 419 3 508 595 3 484 135 3 487 359 3 463 089 3 483 661 3 497 794 3 495 886 Vitality SA June 2024 December 2023 June 2023 December 20222 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Total Vitality Health, Vitality Drive and Vitality Money programme lives 2 922 347 2 822 972 2 652 877 2 498 048 2 348 834 2 242 401 2 163 411 2 122 453 2 065 868 2 060 011 1 987 237 2 restated to include for LA wellness figures VitalityHealth Members June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 140 400 138 278 135 117 129 568 124 395 117 007 113 189 108 955 105 915 104 997 101 702 SME 340 983 327 876 310 624 285 865 263 216 238 540 222 961 211 949 212 305 209 509 201 960 Corporate 120 685 112 941 108 191 102 823 99 578 89 881 86 149 80 514 81 124 78 050 70 583 Trust and Cost Plus 20 237 16 448 16 339 14 511 8 698 3 944 2 731 2 639 - - - Total 622 305 595 543 570 271 532 767 495 887 449 372 425 030 404 057 399 344 392 556 374 245 VitalityHealth Lives June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 260 210 256 527 250 551 238 629 227 684 212 896 204 890 195 996 188 976 186 559 179 811 SME 541 111 522 753 496 299 460 442 429 110 395 777 374 179 357 768 356 907 353 763 342 431 Corporate 191 015 178 163 171 364 163 120 158 890 148 654 143 905 135 218 135 440 131 991 120 157 Trust and Cost Plus 35 163 27 349 26 854 22 673 15 903 6 509 4 066 3 956 - - - Total 1 027 499 984 792 945 068 884 864 831 587 763 836 727 040 692 938 681 323 672 313 642 399 VitalityLife Policies June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Policies 679 382 646 564 622 451 593 322 565 778 535 281 517 913 493 970 474 890 458 675 434 678 VitalityLife Lives June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Lives3 810 050 782 296 764 699 735 137 702 105 669 139 647 020 617 051 594 799 577 965 549 526 3 restated to include unique lives only Discovery Insure Policies June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Policies 214 297 215 297 211 223 214 315 213 453 212 570 202 335 191 936 178 517 169 920 159 171 Discovery Bank June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Primary Clients 958 055 825 069 702,131 581 457 470 220 385 177 331 088 287 183 206 810 61 731 1 476 Total Accounts 2 271 703 1 933 839 1,625,912 1 312 970 1 023 790 793 215 648 546 521 081 357 416 141 660 3 740 2 Membership -- 2 of 15 -- VALUE OF NEW BUSINESS AT POINT OF SALE VS VALUATION DATE June 2024 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (550) (2 833) (1 560) (1 132) (6 075) Value of In Force 1 653 3 393 2 051 1 074 8 171 Cost of Capital (52) (79) (63) (70) (264) 1 051 481 428 (128) 1 832 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 1 615 2 454 1 906 909 6 884 Cost of Capital (51) (79) (60) (68) (258) 1 564 2 375 1 846 841 6 626 December 2023 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (253) (1 452) (754) (635) (3 094) Value of In Force 659 1 739 999 535 3 932 Cost of Capital (21) (45) (53) (35) (154) 385 242 192 (135) 684 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 660 1 256 960 513 3 389 Cost of Capital (21) (45) (52) (28) (146) 639 1 211 908 485 3 243 June 2023 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (485) (2 757) (1 885) (1 845) (6 972) Value of In Force 1 439 3 273 2 154 1 848 8 714 Cost of Capital (39) (87) (87) (89) (302) 915 429 182 (86) 1 440 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 1 434 2 575 1 745 1 907 7 661 Cost of Capital (38) (87) (95) (95) (315) 1 396 2 488 1 650 1 812 7 346 With respect to VitalityLife, the "Acquisition Costs and Initial Strain" and "Value of In-Force" for the VNB at Point of Sale have been restated in prior periods to correctly reflect total acquisition costs and initial commission net of FinRe receivables, with an equal and opposite adjustment to the “Value of In Force”. The Net VNB at Point of Sale for prior periods remains unchanged. 3 Value of New Business -- 3 of 15 -- EV RECONCILIATION TO INCOME STATEMENT for the year ended 30 June 2024 R million Embedded Value Earnings Value of In-Force Cost of required Capital Impact on Income Statement Adjustment to Shareholders Funds Statement of Changes in Equity Total profit from new business 1 832 6 609 (264) (4 513) - - - Health and Vitality 1 051 1 543 (52) (440) - - - Life 481 2 310 (79) (1 750) - - - VitalityHealth 428 1 843 (63) (1 352) - - - VitalityLife (128) 913 (70) (971) - - Profit from existing business * Expected return 10 340 2 716 (72) 7 696 - - - Health and Vitality 3 809 675 7 3 127 - - Expected transfer from VIF to net worth - (3 127) - 3 127 - - Unwinding of the risk discount rate 3 809 3 802 7 - - - - Life 4 596 2 742 (1) 1 855 - - Expected transfer from VIF to net worth - (1 855) - 1 855 - - Unwinding of the risk discount rate 4 596 4 597 (1) - - - - VitalityHealth 911 (784) (46) 1 741 - - Expected transfer from VIF to net worth - (1 741) - 1 741 - - Unwinding of the risk discount rate 911 957 (46) - - - - VitalityLife 1 024 83 (32) 973 - - Expected transfer from VIF to net worth - (973) - 973 - - Unwinding of the risk discount rate 1 024 1 056 (32) - - - * Change in methodology and assumptions 2 385 1 050 1 117 218 - - - Health and Vitality (787) (821) 34 - - - - Life 479 (1 142) (13) 1 634 - - - VitalityHealth 588 284 304 - - - - VitalityLife 2 105 2 729 792 (1 416) - - - - * Experience variances 564 1 049 - (485) - - - Health and Vitality 429 59 (3) 373 - - - Life (40) 334 2 (376) - - - VitalityHealth 305 746 31 (472) - - - VitalityLife (130) (90) (30) (10) - - Increase in goodwill and intangibles (308) - - - (308) - Other initiatives 1 088 24 - 1 064 - - Non-recurring expenses (96) - - (96) - - Acquisition costs (33) (1) - (32) - - Finance costs (2 796) - - (2 796) - - Other 2 - - - 2 - Foreign Exchange Rate Movements (1 555) (1 095) 43 437 170 (1 110) Intangibles 147 - - - 147 - DAC 23 - - - 23 - Other (1 725) (1 095) 43 437 - (1 110) Return on shareholders' funds 1 585 - - 1 523 - 62 Unrealised gain on investments and realised gain on investments transferred to income statement 865 - - 803 - 62 Health and Vitality investment income 106 - - 106 - - Life investment income 614 - - 614 - - VitalityHealth investment income - - - - - - VitalityLife investment income - - - - - - Amortisation of Intangibles (60) - - (435) 375 - Amortisation of intangibles from business combinations (60) - - (91) 31 - Amortisation of systems intangibles - - - (344) 344 - VitalityHealth and VitalityLife DAC and unemployment reserve - - - 271 (271) - Reversal of 1 Discovery Place IFRS 16 financial lease accounting - - - (129) 129 - Life assets under insurance contracts - - - 2 931 (2 931) - VitalityLife net assets under insurance contracts - - - 1 616 (1 616) - Equity settled share based payment mark-to-market adjustment - - - 94 (94) - Embedded value earnings 12 948 10 352 824 7 364 (4 544) (1 048) Adjustment to Shareholders' Funds: Change in: * DAC 655 Intangibles & Goodwill 204 Life negative reserve 5 626 VitalityLife negative reserve 737 1 DP IFRS 16 financial lease accounting 129 Equity settled share based payment mark-to-market adjustment (94) * The change in the adjustments to shareholder’s funds is a on a consistent IFRS 17 basis between 30 June 2024 and 30 June 2023. The reported change in adjustment to shareholder’s funds for 30 June 2023 and prior (in the Group EV Statement) is on an IFRS 4 basis. 4 EV recon -- 4 of 15 -- EV BUILD-UP PER ENTITY for the year ended 30 June 2024 R million Health and Vitality Life and Invest VitalityHealth VitalityLife Other Total Value of in-force business at 30 June 2023 25 473 31 636 12 099 10 682 - 79 890 Expected return (in-force business) 3 721 4 457 826 996 - 10 000 Release of profits (in-force business) (3 127) (1 855) (1 741) (973) - (7 696) Value of new business 1 601 3 314 1 988 981 - 7 884 Expected return (new business) 88 139 85 28 - 340 Release of profits (new business) (110) (1 083) (208) (138) - (1 539) Experience variances 56 336 777 (120) - 1 049 Methodology changes (787) (1 155) 588 3 521 - 2 167 Other (1) 24 (510) (542) - (1 029) Value of in-force business at 30 June 2024 26 914 35 813 13 904 14 435 - 91 066 Shareholders’ funds per Balance Sheet 4 449 30 000 9 184 4 122 9 964 57 719 Adjustment to shareholders' funds - (19 865) (4 351) (11 322) (2 893) (38 431) Embedded value at 30 June 2024 31 363 45 948 18 737 7 235 7 071 110 354 5 EV Buildup per Entity -- 5 of 15 -- COMPONENTS OF ASSETS UNDER INSURANCE CONTRACTS AND ADJUSTMENT TO SHAREHOLDERS' FUNDS ON PUBLISHED BASIS R million June 2024 1. Assets under insurance contracts Discovery Life positive liabilities not netted off with negative liabilities: 627 Discovery Life long term reserves in respect of policies with net negative liabilities: (30 717) Working capital 148 Discovery Life liability for incurred claims (LIC) 7 619 Total Assets under insurance contracts: (22 323) 2. Negative liabilites not included under assets under insurance contracts Negative reserve in respect of Invest business (7 011) DAC and DRL in respect of Invest business (768) (7 779) 3. Components to be zeroised based on the Method of Distributable Cashflows: Discovery Life long term reserves in respect of policies with net negative liabilities: (30 717) Liabilities under reinsurance contracts** 258 Negative reserve in respect of Invest business (7 011) DAC and DRL in respect of Invest business (768) Adjust for reduction on Deferred Tax Liability as a result of reduction in earnings 6 165 Liabilities off set against Negative reserve before zeroisation 12 208 (19 865) ** This amount is the liability under reinsurance contracts, net of CSM, in respect of the portion of the gross assets under insurance contracts zeroised based on the method of distributable cashflows. 4. Other adjustments to published Shareholders' funds VitalityLife net assets under insurance contracts (11 314) VitalityHealth and VitalityHealth Insurance Limited deferred acquisition costs (net of deferred tax) (4 351) VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) (8) Goodwill (2 855) Intangible assets (net of deferred tax) relating to the acquisition of Standard Life Healthcare and the Prudential Assurance Company joint venture (803) Net preference share capital (779) Reversal of 1 Discovery Place IFRS 16 financial lease accounting 1 462 Equity settled share based payment mark-to-market adjustment 82 Adjustment to Shareholders' funds from published basis (38 431) 6 EV Adjustment to SH funds -- 6 of 15 -- RECONCILIATION TO THE REQUIRED CAPITAL for the year ended 30 June 2024 R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Opening - 30 June 2023 1 108 26 011 4 238 10 630 41 987 - Methodology and Basis Changes - (223) (369) 1 684 1 092 - Expected release on in-force at start of period (45) (448) (200) (465) (1 158) - Impact of new business written 197 848 520 1 346 2 911 - Other changes* (22) 1 747 112 (1 436) 401 - Exchange rate movements - - (163) (460) (623) Change in Required Capital 130 1 924 (100) 669 2 623 Closing - 30 June 2024 1 238 27 935 4 138 11 299 44 610 *This line includes, amongst other things, the impact of rebasing the yield curve as part of the opening to closing reconciliation of required capital. This component of the expected yield curve unwind is shown separately from the expected release for information purposes only. For VitalityLife, this line includes the release of the 1.5 times the UK Solvency I long-term insurance capital requirement, with an allowance for the diversification or risk, associated with the VitalityLife business on the PAC license. 7 Recon of Required Capital -- 7 of 15 -- BREAKDOWN OF INVEST ASSETS UNDER ADMINISTRATION R million Total December 2021 127 632 June 2022 121 737 December 2022 130 830 June 2023 140 378 December 2023 144 810 June 2024 154 653 8 Invest AUA -- 8 of 15 -- SA SA SA SA SA UK UK ALL OTHER SEGMENT IFRS R million HEALTH LIFE INVEST INSURE BANK HEALTH LIFE SEGMENTS TOTAL TOTAL 30 June 2024 Income statement Insurance revenue 435 17 249 4 360 5 737 - 16 474 6 904 698 51 857 - 51 857 - Contracts measured under the General measurement model/Variable fee approach - 13 741 4 360 - - - 6 904 - 25 005 - 25 005 - Contracts measured under Premium allocation approach 435 3 508 - 5 737 - 16 474 - 698 26 852 - 26 852 Insurance service expenses ( 341) (15 235) (2 671) (5 471) - (15 456) (6 217) ( 754) (46 145) - (46 145) - Claims and benefits ( 224) (12 104) ( 462) (3 540) - (9 562) (3 098) ( 472) (29 462) - (29 462) - Insurance service expense and other ( 54) (1 124) (1 148) (1 069) - (4 127) ( 509) ( 135) (8 166) - (8 166) - Insurance acquisition cash flows ( 63) (2 007) (1 061) ( 862) - (1 767) (2 610) ( 147) (8 517) - (8 517) Insurance service result (pre-reinsurance) 94 2 014 1 689 266 - 1 018 687 ( 56) 5 712 - 5 712 Net income/(expenses) from reinsurance contracts ( 1) ( 458) - ( 24) - ( 8) ( 408) ( 16) ( 915) - ( 915) - Reinsurance expense ( 1) (3 692) - ( 474) - ( 8) (5 738) ( 275) (10 188) - (10 188) - Insurance claims recovered from reinsurers - 3 234 - 450 - - 5 330 259 9 273 - 9 273 Insurance service result 93 1 556 1 689 242 - 1 010 279 ( 72) 4 797 - 4 797 Net financial result from insurance finance income and expense - 2 674 (9 850) - - - 231 - (6 945) ( 300) (7 245) - Net finance income/(expense) from insurance contracts - 2 869 (9 850) - - - 379 - (6 602) ( 300) (6 902) - Net finance expense from reinsurance contracts - ( 195) - - - - ( 148) - ( 343) - ( 343) Investment income earned on assets backing policyholder liabilities - 22 49 209 - 175 65 22 542 318 860 Net fair value (losses)/gains on financial instruments at fair value through profit or loss ( 6) 971 10 098 1 1 60 - 1 401 12 526 3 719 16 245 Fair value adjustments to liabilities under investment contracts - ( 1) ( 738) - - - - (1 403) (2 142) - (2 142) Third party interest: fair value adjustments to liabilities under investment contracts - - - - - - - - - (2 873) (2 873) Intersegment funding ( 13) ( 169) 169 13 - - - - - - - Other gains and losses on financial instruments - - - - 5 - - - 5 - 5 Net investment and financial results 74 5 053 1 417 465 6 1 245 575 ( 52) 8 783 864 9 647 Fee income from administration businesses 9 233 - 1 712 - - 54 - 3 094 14 093 - 14 093 Vitality income - - - - - 640 264 3 751 4 655 - 4 655 Net banking fee and commission income - - - - 1 367 - - 31 1 398 - 1 398 - Banking fee and commission income - - - - 1 872 - - - 1 872 - 1 872 - Banking fee and commission expense - - - - ( 505) - - 31 ( 474) - ( 474) Net bank interest and similar income - - - - 779 - - - 779 - 779 - Bank interest and similar income using the effective interest rate - - - - 1 840 - - - 1 840 - 1 840 - Bank interest and similar expense using the effective interest rate - - - - (1 061) - - - (1 061) - (1 061) Other income 1 173 3 - 16 - 42 - 86 1 320 60 1 380 Non-insurance revenue and income 10 406 3 1 712 16 2 146 736 264 6 962 22 245 60 22 305 Net income 10 480 5 056 3 129 481 2 152 1 981 839 6 910 31 028 924 31 952 Acquisition costs - - ( 880) - - - - ( 108) ( 988) - ( 988) Expected credit losses - - - - ( 183) - - - ( 183) - ( 183) Marketing and administration expenses - - - - - - - - - - - - depreciation and amortisation ( 171) - ( 17) ( 72) ( 339) ( 465) ( 49) ( 822) (1 935) ( 224) (2 159) - derecognition of intangible assets and property and equipment - - - ( 16) - ( 1) - ( 38) ( 55) - ( 55) - impairment of intagible assets and property and equipment - - - - - ( 13) - ( 9) ( 22) - ( 22) - other expenses (6 337) ( 291) ( 710) ( 194) (2 084) (1 065) ( 421) (6 164) (17 266) ( 142) (17 408) Share of net profits from equity-accounted investments - - - 49 - ( 2) 6 972 1 025 ( 50) 975 Normalised profit/(loss) from operations 3 972 4 765 1 522 248 ( 454) 435 375 741 11 604 508 12 112 Fair value losses on VitalityLife interest rate derivatives - - - - - - - - - - - Investment income earned on shareholder investments and cash 120 27 16 - - - - 155 318 ( 318) - Intercompany investment income - - - - - - - 1 046 1 046 (1 046) - Net fair value (losses)/gains on financial assets at fair value through profit or loss - 87 75 - - - - - 162 ( 162) - Gain/(Loss) from dilution of equity accounted investments - - - 22 - - - - 22 - 22 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Impairment of goodwill - - - - - - - - - - - - - - - - - - - - - - Amortisation of intangibles from business combinations - - - ( 49) - - - ( 56) ( 105) 105 - - - - - - - - - - - - - - - - - - - - - - - Market rentals related to Head Office building adjusted for finance costs and depreciation - - - - - - - ( 105) ( 105) 105 - Restructuring costs - - - - - - - ( 48) ( 48) 48 - Interest expenses on borrowings and lease liabilities ( 2) ( 1) - - - ( 17) ( 217) (1 513) (1 750) ( 286) (2 036) Intercompany finance expenses on borrowings ( 412) - - - - - ( 464) ( 170) (1 046) 1 046 - Foreign exchange gains/(losses) ( 6) ( 11) ( 20) - - - - ( 50) ( 87) - ( 87) Profit/(loss) before income tax 3 672 4 867 1 593 221 ( 454) 418 ( 306) - 10 011 - 10 011 Income tax expense ( 987) (1 314) ( 339) ( 58) 171 ( 144) 25 ( 1) (2 647) - (2 647) Profit/(loss) for the year 2 685 3 553 1 254 163 ( 283) 274 ( 281) ( 1) 7 364 - 7 364 Profit attributable to: - Ordinary shareholders 2 695 3 553 1 254 163 ( 283) 274 ( 281) ( 92) 7 283 - 7 283 - Preference shareholders - - - - - - - 91 91 - 91 - Non-controlling interest ( 10) - - - - - - - ( 10) - ( 10) Segment information IFRS REPORTING ADJUSTMEN -- 9 of 15 -- VIF, APE AND VNB SPLIT BETWEEN LIFE AND INVEST R million June 2024 December 2023 June 2023 December 2022 June 2022 VIF1 Life 24 138 22 859 22 244 23 133 22 059 Invest 11 675 10 429 9 393 9 521 8 505 APE2 Life 804 426 823 463 837 Invest 2 411 1 150 2 142 1 033 2 158 VNB1 Life 225 136 162 169 364 Invest 256 106 267 160 341 1 These VIF and VNB numbers are after allowing for the Cost of required Capital. 2 APE is the Annual Premium Income (or Annual Premium Equivalent in the case of Single Premium Investment business) in relation to New Business only, and excludes any addition to Existing Business premiums arising from servicing increases and ACIs. Discovery Retirement Optimiser (DRO) product moved from Life to Invest in line with disclosures for December 2016 and later periods. 10 Results split Life and Invest -- 10 of 15 -- Group Shareholder Free Cash Movement R millions FY2024 HY2024 FY2023 HY2023 Cash Generated from In-Force Before Financing and Tax1,2 14 617 7 567 14 425 6 903 New Business2 (6 823) (3 528) (7 243) (3 408) Tax Paid (1 522) (792) (1 839) (1 042) Operating cash flow 6 272 3 247 5 343 2 453 New Initiatives (1 025) (776) (1 671) (800) Business Development and Other (1 580) (864) (1 274) (434) Finance Cost Paid (1 566) (802) (1 501) (786) Dividends Paid (1 270) (783) (69) (31) Financing and Matching Initiatives2 (496) (332) 166 150 Transactions with Borrowers (Excl. Finance Costs)1 1 130 (80) (597) (463) Movement in Shareholder Free Cash 1 465 (390) 397 89 Remove ordinary shareholder dividend paid in shareholder cash flow period 1 178 740 - - Add ordinary shareholder dividend paid in respect of shareholder cash flow period (1 467) (439) (740) - Movement in Shareholder Free Cash – Dividend Accrual Basis3 1 176 (89) (343) 89 Group Shareholder Free Cash Movement - Reconciliation to Profit for the Period R millions FY2024 HY2024 FY2023 HY2023 Profit for the period 7 364 3 343 5 320 2 943 Reverse non-cash profit items: Share of net profits/(losses) from equity accounted investments (1 031) (302) (561) (76) Gains from dilution of equity accounted investments (22) - 5 - Depreciation and amortisation 2 160 1 040 1 972 957 Impairment of intangible assets 45 4 61 4 Deferred acquisition costs (Excl. Invest DAC and exchange rate movements) (42) (14) Movement in contract assets (640) (252) 52 31 Amortisation of intangibles from business combinations - - 56 27 Non cash impact of Vitality Health DAC (411) (206) (753) (292) Non-cash fair value gains on financial assets (87) (56) (214) (43) Non-cash forex gains / losses - - 9 (1) Other non-cash adjustments to profit1 (152) (64) (178) (44) Adjustments from IFRS to EV ANW: Increase in Negative Reserves and Invest DAC (Net of tax) (4 547) (1 767) (4 141) (1 735) Exchange rate movements on Vitality Life Negative Reserves (385) (137) 1 900 195 Other adjustments to arrive at EV ANW4 1 644 137 196 104 Incurred to Cash basis: - Rent Paid (511) (286) (328) (158) - Finance Costs Paid (2 603) (802) (1 501) (932) - Finance Costs Accrued 3 097 1 025 1 941 930 - Taxation paid (1 522) (792) (1 839) (1 042) - Taxation Accrued 1 093 810 1 495 741 Investing Activities: Purchase of property and equipment (414) (246) (551) (210) Proceeds from disposal of property and equipment 28 2 2 Purchase of intangible assets (1 789) (800) (1 760) (751) Increase in investment in associate 287 (176) (75) (53) Acquisition of business net of cash required - - (3) - Financing Activities: Increase in borrowings 2 005 500 7 441 3 855 Repayment of borrowings1 (874) (580) (8 038) (4 318) Dividends paid to ordinary shareholders (1 179) (739) - - Dividends paid to preference shareholders (91) (44) (69) (31) Movement in Shareholder Free Cash 1 465 (390) 397 89 Notes "Movement in Shareholder Free Cash" is an estimate of shareholder free cashflow. Life and Invest and VitalityLife are included based on the change in the Adjusted Net Worth in the Embedded Value. Changes in working capital are not allowed for in the estimate. 1) HY2023 and FY2023: Reallocation of rental paid on finance leases from "Transactions with Borrowers" to "Cash Generated from In-Force". This value was immaterial in all other periods. 2) Prior to FY2024 "Financing and Matching Initiatives", previously disclosed as "Transactions with Reinsurers", included the net external FinRe cash flows for VitalityLife. From FY2024, and restated for prior periods, the net external FinRe cash flows for VitalityLife have been reallocated to "Operating Cash Flow", with FinRe repayments included in "Cash Generated from In-Force Before Financing and Tax" and new FinRe receivables offset against "New Business". 3) This view of the movement in shareholder free cash flow aligns the dividend paid to the period against which the cash flow was generated to fund it. For the year ended 30 June 2024, the interim declared dividend of R439m, per the interim financial results, and the final declared dividend of R1 028m, per the annual financial results, are used as the total dividend accrued in respect of the twelve-month period. 4) For FY2024, this adjustment considers the VitalityLife modelling change which reallocated the capitalised impact of deferred tax relief on future earnings between adjusted net worth and value of in-force. This modelling change impacts the EV adjusted net worth, but is not considered a shareholder cash flow impact, and is therefore reversed from the Movement in Shareholder Free Cash Flow build-up. -- 11 of 15 -- Reconciliation of operating profit to normalised operating profit for the year ended 30 June 2024 Group Group Year ended June 2024 Year ended June 2024 R million change Operating profit 11 137 10 308 8% Share of net profits from equity accounted investments 975 525 Impairment of goodwill - 9 Normalised profit from operations per Segment information (IFRS total) 12 112 10 842 12% Normalised profit adjustments ( 508) ( 925) Investment income earned on shareholder investments and cash ( 318) ( 216) Difference between market related rental and depreciation and finance costs (Head office) ( 181) ( 157) Net fair value gains on financial assets at fair value through profit or loss ( 162) ( 138) VitalityLife interest rate derivative - ( 516) Amortisation of intangibles from business combinations 105 102 Restructuring costs 48 - Normalised profit from operations 11 604 9 917 17% 12 Op Profit recon -- 12 of 15 -- NAV PER ENTITY for the year ended June 2024 Covered businesses June 2024 NAV before adjustment to shareholder funds Health and Vitality 4 449 Life and Invest 30 000 VitalityHealth 9 184 VitalityLife 4 122 Non-covered business Bank, including DCS intangible asset and goodwill 7 773 Insure 2 060 PAHI 6 225 CMT 1 561 Limited (11 517) Other 3 863 Total NAV 57 719 -- 13 of 15 -- RMB million (except lives) June 2024 June 2023 Change New business PAHI own licence (100%) 3 842 3 428 12% New business PAHI Reinsurance 533 289 84% New business PAHI total (100%) 4 375 3 717 18% Written premium-own licence 16 118 14 318 13% Written premium-reinsurance 6 527 5 314 23% Total written premium (100%) 22 645 19 632 15% Earned premiums – Total 15 320 14 281 7% Total investable assets 23 328 19 869 17% Lives-own licence 27 22 26% Lives-reinsurance 8 6 26% Total lives 35 28 26% PAHI profit before income and gains (100%) 1 470 881 67% PAHI investment income and gains (100%) 621 456 36% PAHI pre-tax profit (100%) 2 092 1 337 56% -- 14 of 15 -- -- 15 of 15 --